Target Expands Beauty Strategy With 600-Store Studio Rollout

Target is expanding its Beauty strategy with the Sept. 10 launch of Target Beauty Studio in 600+ stores and on Target.com, featuring 1,600+ products from 90 brands (with two-thirds new to Target). Beauty net sales grew to $3,639M in Q2 FY26 from $3,396M a year earlier, supporting management’s view of sustained guest response to prior Beauty investments. The stock has also benefited from improving sentiment/estimates, with the Zacks EPS consensus rising by $2.08 to $10.42 for the current fiscal year over 30 days and shares up 31.9% over the past three months.

Analysis

Target’s beauty push is less about category revenue and more about improving store productivity: higher-velocity SKUs, better trip frequency, and a cleaner way to reassert relevance without a broad price war. The incremental margin upside is real if the mix is vendor-funded and the concept lifts basket size, but the flip side is execution risk from labor, planogram complexity, and shrink in a fragmented, fast-refresh category. The most exposed losers are mass-market beauty incumbents and drugstore chains, because this is about discovery and trial siphoning, not just shelf expansion.

Near term, the stock can keep working because the market rewards any credible sign that Target is moving from traffic erosion to traffic creation, but this is still a merchandising story until it shows up in comp, gross margin, and repeat visits. The launch should be judged over the next 1-3 quarters, not days; if beauty growth merely offsets softness elsewhere, the multiple expansion case stalls. Six to eighteen months out, sustained success could justify a modest rerating, but only if it proves sticky enough to improve the whole-store customer funnel rather than cannibalize adjacent discretionary spend.

The consensus may be overestimating how much a prestige-inflected beauty concept changes Target’s core earnings power. Beauty is a strong signal of operational intent, but it is not a fix for broader retail mix issues, so the move is probably incremental rather than transformative. The key falsifier is simple: if the next two earnings prints fail to show beauty-led comp acceleration and SG&A leverage, this becomes a story stock with limited follow-through.

Key Decisions for Investors

• Tactical long TGT on post-launch weakness only; use a 1-2 quarter holding period and exit if beauty does not add visible comp lift by the next earnings print.
• If sentiment remains constructive, express the view with a TGT call spread into the next quarterly report rather than outright stock, since the catalyst is real but the upside is likely capped absent broader core improvement.
• Relative-value idea: long TGT / short COST for a 1-3 month trade if you expect merchant-relevance to matter more than quality/valuation in the near term; cover if COST re-accelerates or TGT’s multiple expands without EPS follow-through.
• Watch CVS and WBA as second-order losers; if industry scan data shows Target taking beauty share, consider a short on mass beauty/drugstore exposure over a 1-6 month horizon.